Z
ZBIO
Zenas BioPharma Inc.
31.84
+0.22+0.70%Opening13:40 08/21 EDT
OPEN/PREV CLOSE31.83/31.62
TODAY RANGE31.45-32.79
VOL307.22K
MARKET CAP2.08B
52 WEEK RANGE13.50-44.60
AVG VOL (3M)842.49K
% TURNOVER0.47%
TURNOVER--
P/E (TTM)-3.5487
% RANGE4.24%
EPS(TTM)-8.9724
P/E(FORWARD)-5.4708
P/B8.16
BVPS3.902
DIVIDEND--
P/S173.51
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.65B
SHARES OUTSTANDING65.18M
NEXT EARNINGS11/10-11/16
FREE FLOAT51.91M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Zenas BioPharma (ZBIO) Looks Pricey Following Weak Q2 Results And Leadership Changes
TipRanks·4d ago
Zenas BioPharma CFO Jennifer Fox to transition out of role
Dow Jones·6d ago
Zenas BioPharma Is Maintained at Equal-Weight by Morgan Stanley
TipRanks·08/14 14:06
Wedbush Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)
Dow Jones·08/14 13:46
Zenas BioPharma Price Target Maintained With a $55.00/Share by Guggenheim
Benzinga·08/14 13:37
Guggenheim Reiterates Buy on Zenas BioPharma, Maintains $55 Price Target
Dow Jones·08/14 13:17
Zenas BioPharma Price Target Maintained With a $45.00/Share by Wedbush
Benzinga·08/14 13:07
Wedbush Reiterates Outperform on Zenas BioPharma, Maintains $45 Price Target
TipRanks·08/14 12:38
Morgan Stanley Reaffirms Their Hold Rating on Zenas BioPharma, Inc. (ZBIO)
TipRanks·08/14 12:18
Zenas BioPharma, Inc. (ZBIO) Receives a Buy from Guggenheim
Simply Wall St·08/14 07:24
Zenas BioPharma (ZBIO) Is Down 9.2% After Wider Losses And Leadership Changes - What's Changed
Same Industry
Name/Symbol
Change%
Price